Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

  1. Herzog, T.J.
  2. Wahab, S.A.
  3. Mirza, M.R.
  4. Pothuri, B.
  5. Vergote, I.
  6. Graybill, W.S.
  7. Malinowska, I.A.
  8. York, W.
  9. Hurteau, J.A.
  10. Gupta, D.
  11. González-Martin, A.
  12. Monk, B.J.
Zeitschrift:
International Journal of Gynecological Cancer

ISSN: 1525-1438,  1048-891X

Datum der Publikation: 2023

Ausgabe: 33

Nummer: 11

Seiten: 1733-1742

Art: Artikel

DOI: 10.1136/IJGC-2023-004605 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus